Summary

The flow cytometry market in the Asia Pacific region is on the brink of significant growth, driven by technological advancements and rising demand across multiple sectors.In 2024, the market size is projected to reach USD 899.8 million, with a forecasted expansion to USD 1,289 million by 2031, growing at a compound annual growth rate (CAGR) of 5.30%. This market, which includes the use of flow cytometers for immunophenotyping, diagnostics, and research, is anticipated to expand considerably in the upcoming years.

Market Overview

Flow cytometry, a technique that enables the rapid and detailed analysis of individual cells suspended in a liquid stream, is gaining traction in the Asia Pacific region. By utilizing lasers to produce scattered and fluorescent light signals, flow cytometers offer valuable insights into immune cell counts, cell cycle stages, cancer cell detection, and molecular interactions. These capabilities have made flow cytometry an essential tool in medical diagnostics and research.

Market Growth and Projections

The Asia Pacific flow cytometry market is experiencing robust growth, with forecasts indicating a notable rise in market value. Several factors are contributing to this growth, including technological advancements and increased adoption across various sectors. The market, which has demonstrated consistent growth, is expected to continue on this positive trajectory.

Impact of COVID-19

The COVID-19 pandemic has significantly impacted the flow cytometry market in Asia Pacific. The pandemic exposed the limitations of conventional testing methods such as PCR and antibody tests, leading to a surge in demand for flow cytometry. This technique, known for its precision and high-throughput capabilities, was crucial during the pandemic. The increased demand has prompted manufacturers to innovate and develop more advanced systems, further fueling market growth.

Technological Advancements

Technological progress in flow cytometry has been a major driver of market growth. Recent innovations include high-throughput flow cytometry and the development of advanced systems that offer greater efficacy and address industry challenges. These advancements have greatly enhanced the utility of flow cytometry, making it a preferred choice for researchers and clinicians.

Market Dynamics

Growing Demand for Healthcare Services

The need for flow cytometers is rising due to the increasing demand for high-quality healthcare services in ASEAN countries. Flow cytometry has become a routine tool for clinical pathologists and immunologists, used extensively for diagnosing and monitoring cancer and immunological deficiencies. The advent of high-throughput flow cytometry has further expanded its utility by enabling simultaneous analysis of multiple samples.

Challenges in Adoption

Despite the positive outlook, the high cost associated with acquiring and maintaining advanced flow cytometers remains a significant challenge. The expense of these sophisticated devices, along with maintenance fees and other indirect costs, can be substantial. This financial barrier impacts the ability of some institutions, especially in emerging countries, to fully utilize flow cytometry equipment.

Regional Insights

Australia

Australia is emerging as a key market for flow cytometers, driven by increased government investment in diagnostic research and development. The country’s commitment to advancing research and development, supported by significant public and private sector funding, continues to drive growth in the flow cytometry market.

South Korea

South Korea is making notable progress in enhancing flow cytometry techniques, focusing on high-content screening and multiparameter analysis. These advancements have improved the ability to conduct comprehensive investigations of complex biological systems, contributing to the region’s substantial market share.

Indonesia

In Indonesia, the growing prevalence of chronic and infectious diseases is boosting the demand for flow cytometers. Healthcare practitioners in the country are increasingly using flow cytometry for real-time analysis of cellular composition and immunological pathways. Despite challenges related to organizing and funding R&D initiatives, the demand for flow cytometry technology remains strong.

Segment Analysis

Consumables

In the Asia Pacific flow cytometry market, consumables, such as reagents and accessories, dominate the market. These products are crucial for various assays and are used extensively in flow cytometry applications, driving their high demand.

Applications

Among the different applications of flow cytometry, immunophenotyping stands out. This technique is widely utilized for evaluating cell types and detecting deviations in antigen production. Its efficiency in characterizing different cell types makes it a vital component of flow cytometry applications.

Research Applications

Flow cytometry plays a significant role in research, with a large portion of its applications dedicated to research purposes. The technology’s ability to perform detailed analyses and investigations, especially in stem cell research and clinical studies, highlights its importance in the research community.

Competitive Analysis

•Beckman Coulter

•Becton Dickinson & Co.

•Life Technologies Corporation (Thermo Fisher Scientific Inc.)

•Miltenyi Biotec

•Luminex Corp.

•Merck KGaA

•bioMérieux SA

•Agilent Technologies

•Bio-Rad Laboratories

•Apogee Flow Systems Ltd.

•Stratedigm, Inc.

•Sysmex Partec

•Sony Biotechnology

•Cytek® Biosciences

•Sartorius AG

•Hamamatsu Photonics K.K

•FURUKAWA ELECTRIC CO., LTD

•Accellix

•Shenzhen Mindray BioMedical Electronics Co., Ltd



Asia Pacific Flow Cytometry Industry Segmentation

Product:

•Flow Cytometer Systems

oTraditional Flow Cytometers

Cell Sorters

Imaging Flow Cytometers

oAcoustic Focusing Cytometers

oNext-generation Flow Cytometers

•Reagents, Consumables, & Accessories

•Software

•Services

Application:

•Immunophenotyping

•Cell Sorting

•Cell Cycle Analysis

oApoptosis

oCell Proliferation Assays

oIntracellular Calcium Flux

•Detection & Sorting of Exosomes

•Others

Usage:

•Research Use

•Clinical Diagnostics

End User:

•Hospitals

•Diagnostic Laboratories

•Academic & Research Institutes

•Biopharmaceutical Companies

Country:

•South Korea

•Hong Kong

•Taiwan

•Australia

•New Zealand

•Indonesia

•Thailand

•Malaysia

•Vietnam

•Singapore

•Philippines

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Asia Pacific Flow Cytometry Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Price Analysis, 2019 - 2023
3.1. Global Average Price Analysis, by Product Type, US$ Per Unit, 2019 - 2023
3.2. Prominent Factor Affecting Multilayer Ceramic Capacitors Prices
3.3. Global Average Price Analysis, by Region, US$ Per Unit
4. Asia Pacific Flow Cytometry Market Outlook, 2019 - 2031
4.1. Asia Pacific Flow Cytometry Market Outlook, by Product Type, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.1.1. Key Highlights
4.1.1.1. Flow Cytometer Systems
4.1.1.1.1. Traditional Flow Cytometers
4.1.1.1.1.1. Cell Sorters
4.1.1.1.1.2. Imaging Flow Cytometers
4.1.1.1.2. Acoustic Focusing Cytometers
4.1.1.1.3. Next-generation Flow Cytometers
4.1.1.2. Reagents, Consumables, & Accessories
4.1.1.3. Software
4.1.1.4. Services
4.2. Asia Pacific Flow Cytometry Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.2.1. Key Highlights
4.2.1.1. Immunophenotyping
4.2.1.2. Cell Sorting
4.2.1.3. Cell Cycle Analysis
4.2.1.3.1. Apoptosis
4.2.1.3.2. Cell Proliferation Assays
4.2.1.3.3. Intracellular Calcium Flux
4.2.1.4. Detection & Sorting of Exosomes
4.2.1.5. Others
4.3. Asia Pacific Flow Cytometry Market Outlook, by Usage, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.3.1. Key Highlights
4.3.1.1. Research Use
4.3.1.2. Clinical Diagnostics
4.4. Asia Pacific Flow Cytometry Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.4.1. Key Highlights
4.4.1.1. Hospitals
4.4.1.2. Diagnostic Laboratories
4.4.1.3. Academic & Research Institutes
4.4.1.4. Biopharmaceutical Companies
4.5. Asia Pacific Multilayer Ceramic Capacitors Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1. Key Highlights
4.5.1.1. China Multilayer Ceramic Capacitors Market by Product Type, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.2. China Multilayer Ceramic Capacitors Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.3. China Multilayer Ceramic Capacitors Market by Usage, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.4. China Multilayer Ceramic Capacitors Market by End User, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.5. Japan Multilayer Ceramic Capacitors Market by Product Type, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.6. Japan Multilayer Ceramic Capacitors Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.7. Japan Multilayer Ceramic Capacitors Market by Usage, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.8. Japan Multilayer Ceramic Capacitors Market by End User, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.9. South Korea Multilayer Ceramic Capacitors Market by Product Type, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.10. South Korea Multilayer Ceramic Capacitors Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.11. South Korea Multilayer Ceramic Capacitors Market by Usage, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.12. South Korea Multilayer Ceramic Capacitors Market by End User, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.13. India Multilayer Ceramic Capacitors Market by Product Type, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.14. India Multilayer Ceramic Capacitors Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.15. India Multilayer Ceramic Capacitors Market by Usage, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.16. India Multilayer Ceramic Capacitors Market by End User, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.17. Southeast Asia Multilayer Ceramic Capacitors Market by Product Type, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.18. Southeast Asia Multilayer Ceramic Capacitors Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.19. Southeast Asia Multilayer Ceramic Capacitors Market by Usage, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.20. Southeast Asia Multilayer Ceramic Capacitors Market by End User, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.21. Rest of Asia Pacific Multilayer Ceramic Capacitors Market by Product Type, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.22. Rest of Asia Pacific Multilayer Ceramic Capacitors Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.23. Rest of Asia Pacific Multilayer Ceramic Capacitors Market by Usage, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.5.1.24. Rest of Asia Pacific Multilayer Ceramic Capacitors Market by End User, Value (US$ Mn) and Volume (Units), 2019 - 2031
5. Competitive Landscape
5.1. Product Type vs Application Heatmap
5.2. Company Market Share Analysis, 2023
5.3. Competitive Dashboard
5.4. Company Profiles
5.4.1. Beckman Coulter
5.4.1.1. Company Overview
5.4.1.2. Product Portfolio
5.4.1.3. Financial Overview
5.4.1.4. Business Strategies and Development
5.4.2. Becton Dickinson & Co.
5.4.2.1. Company Overview
5.4.2.2. Product Portfolio
5.4.2.3. Financial Overview
5.4.2.4. Business Strategies and Development
5.4.3. Life Technologies Corporation (Thermo Fisher Scientific Inc.)
5.4.3.1. Company Overview
5.4.3.2. Product Portfolio
5.4.3.3. Financial Overview
5.4.3.4. Business Strategies and Development
5.4.4. Miltenyi Biotec
5.4.4.1. Company Overview
5.4.4.2. Product Portfolio
5.4.4.3. Financial Overview
5.4.4.4. Business Strategies and Development
5.4.5. Luminex Corp.
5.4.5.1. Company Overview
5.4.5.2. Product Portfolio
5.4.5.3. Financial Overview
5.4.5.4. Business Strategies and Development
5.4.6. Merck KGaA
5.4.6.1. Company Overview
5.4.6.2. Product Portfolio
5.4.6.3. Financial Overview
5.4.6.4. Business Strategies and Development
5.4.7. bioMérieux SA
5.4.7.1. Company Overview
5.4.7.2. Product Portfolio
5.4.7.3. Financial Overview
5.4.7.4. Business Strategies and Development
5.4.8. Agilent Technologies
5.4.8.1. Company Overview
5.4.8.2. Product Portfolio
5.4.8.3. Financial Overview
5.4.8.4. Business Strategies and Development
5.4.9. Bio-Rad Laboratories
5.4.9.1. Company Overview
5.4.9.2. Product Portfolio
5.4.9.3. Financial Overview
5.4.9.4. Business Strategies and Development
5.4.10. Apogee Flow Systems Ltd.
5.4.10.1. Company Overview
5.4.10.2. Product Portfolio
5.4.10.3. Financial Overview
5.4.10.4. Business Strategies and Development
5.4.11. Stratedigm, Inc.
5.4.11.1. Company Overview
5.4.11.2. Product Portfolio
5.4.11.3. Financial Overview
5.4.11.4. Business Strategies and Development
5.4.12. Sysmex Partec
5.4.12.1. Company Overview
5.4.12.2. Product Portfolio
5.4.12.3. Financial Overview
5.4.12.4. Business Strategies and Development
5.4.13. Sony Biotechnology
5.4.13.1. Company Overview
5.4.13.2. Product Portfolio
5.4.13.3. Financial Overview
5.4.13.4. Business Strategies and Development
5.4.14. Cytek® Biosciences
5.4.14.1. Company Overview
5.4.14.2. Product Portfolio
5.4.14.3. Financial Overview
5.4.14.4. Business Strategies and Development
5.4.15. Sartorius AG
5.4.15.1. Company Overview
5.4.15.2. Product Portfolio
5.4.15.3. Financial Overview
5.4.15.4. Business Strategies and Development
5.4.16. Hamamatsu Photonics K.K
5.4.16.1. Company Overview
5.4.16.2. Product Portfolio
5.4.16.3. Financial Overview
5.4.16.4. Business Strategies and Development
5.4.17. FURUKAWA ELECTRIC CO., LTD
5.4.17.1. Company Overview
5.4.17.2. Product Portfolio
5.4.17.3. Financial Overview
5.4.17.4. Business Strategies and Development
5.4.18. Accellix
5.4.18.1. Company Overview
5.4.18.2. Product Portfolio
5.4.18.3. Financial Overview
5.4.18.4. Business Strategies and Development
5.4.19. Shenzhen Mindray BioMedical Electronics Co., Ltd
5.4.19.1. Company Overview
5.4.19.2. Product Portfolio
5.4.19.3. Financial Overview
5.4.19.4. Business Strategies and Development
6. Appendix
6.1. Research Methodology
6.2. Report Assumptions
6.3. Acronyms and Abbreviations